Immunovant, Inc. (IMVT) Earnings Call Analysis
NASDAQ · Unknown · Unknown
Next earnings call: 2026-08-06
(Q1 2026)
— full calendar
Earnings Reports
-
Immunovant (IMVT) Q3 2025: BREPO 45mg Delivers 100% Responder Rate, Accelerating Pipeline Momentum
June 15, 2026
-
Immunovant (IMVT) Q2 2025: $1.5B Buyback Shrinks Share Count 15% Ahead of Brepocitinib Data Catalyst
August 11, 2025
-
Immunovant (IMVT) Q4 2024: $1.3B Buyback and $5B Cash Set Stage for Multi-Blockbuster Pipeline
July 03, 2025